Neuropsychopharmacology, Published online: 15 September 2026; doi:10.1038/s41386-026-02526-8

Neuropsychopharmacology, Published online: 15 September 2026; doi:10.1038/s41386-026-02526-8

L. Eugene “Gene” Arnold, a friend, teacher, and luminary in child and adolescent psychiatry, died at age 89 at his beloved farm in Sunbury, Ohio. A medical graduate of The Ohio State University (OSU) College of Medicine and an alumnus of the general and child and adolescent psychiatry training programs at Johns Hopkins University, Dr. Arnold remained an active member of the OSU Department of Psychiatry and Behavioral Health for 55 years. His work as an outstanding clinician, researcher, educator, mentor, and thought leader in our field contributed important advancements in the care of individuals with autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD).

L. Eugene “Gene” Arnold, a friend, teacher, and luminary in child and adolescent psychiatry, died at age 89 at his beloved farm in Sunbury, Ohio. A medical graduate of The Ohio State University (OSU) College of Medicine and an alumnus of the general and child and adolescent psychiatry training programs at Johns Hopkins University, Dr. Arnold remained an active member of the OSU Department of Psychiatry and Behavioral Health for 55 years. His work as an outstanding clinician, researcher, educator, mentor, and thought leader in our field contributed important advancements in the care of individuals with autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD).

L. Eugene “Gene” Arnold, a friend, teacher, and luminary in child and adolescent psychiatry, died at age 89 at his beloved farm in Sunbury, Ohio. A medical graduate of The Ohio State University (OSU) College of Medicine and an alumnus of the general and child and adolescent psychiatry training programs at Johns Hopkins University, Dr. Arnold remained an active member of the OSU Department of Psychiatry and Behavioral Health for 55 years. His work as an outstanding clinician, researcher, educator, mentor, and thought leader in our field contributed important advancements in the care of individuals with autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD).

L. Eugene “Gene” Arnold, a friend, teacher, and luminary in child and adolescent psychiatry, died at age 89 at his beloved farm in Sunbury, Ohio. A medical graduate of The Ohio State University (OSU) College of Medicine and an alumnus of the general and child and adolescent psychiatry training programs at Johns Hopkins University, Dr. Arnold remained an active member of the OSU Department of Psychiatry and Behavioral Health for 55 years. His work as an outstanding clinician, researcher, educator, mentor, and thought leader in our field contributed important advancements in the care of individuals with autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD).

L. Eugene “Gene” Arnold, a friend, teacher, and luminary in child and adolescent psychiatry, died at age 89 at his beloved farm in Sunbury, Ohio. A medical graduate of The Ohio State University (OSU) College of Medicine and an alumnus of the general and child and adolescent psychiatry training programs at Johns Hopkins University, Dr. Arnold remained an active member of the OSU Department of Psychiatry and Behavioral Health for 55 years. His work as an outstanding clinician, researcher, educator, mentor, and thought leader in our field contributed important advancements in the care of individuals with autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD).

Neuropsychopharmacology, Published online: 18 July 2026; doi:10.1038/s41386-026-02501-3

Source: Clinical Psychology Review, Volume 128

Source: Clinical Psychology Review, Volume 128

Source: Neuropharmacology

Adolescent substance use and addiction sit among the most pressing and rapidly evolving challenges in child and adolescent psychiatry today. Alcohol, nicotine, and cannabis remain the most commonly used psychoactive substances among adolescents. Monitoring the Future data from 2025 continue to highlight substantial exposure across developmental stages, with past-year alcohol use reported by 11% of eighth graders, 24% of tenth graders, and 41% of twelfth graders; cannabis use by 8%, 16%, and 26%, respectively; and nicotine vaping by 9%, 14%, and 20% of students across the same grade levels.

CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA